Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects

Clinical trial NCT05492630 · COMPLETED

Trial details

NCT number: NCT05492630
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Nephropathy

Start date: 2021-05-24
Primary completion: 2023-01-04
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.